Skip to content

TARGET Efficacy

The Efficacy of TARGET Model in Reducing Anxiety Symptoms and Correlates of Trauma among Women with Anxiety Disorders who had histories of Childhood Trauma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191230045947N1
Enrollment
40
Registered
2020-07-19
Start date
2020-08-22
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Anxiety Disorders. Condition 2: Childhood Trauma. Phobic anxiety disorders Childhood emotional disorder, unspecified

Interventions

Intervention 1: Intervention group: TARGET Group Therapy. TARGET (Trauma Affect Regulation: Guide for Education and Therapy) is one of the new methods of cognitive-behavioral therapy, useful for traum
Chlorodiazepoxide 10, once per night
S Citalopram 10, once per night
Clonazepam 1, once per night
Gabapentin 100 capsules, consuming in the morning, noon, and at night. The duration of usage, depending on the severity of the disorder and after the control of symptoms, lasts for six months to one y

Sponsors

University of social welfare and rehabilitation sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: History of childhood trauma suffering from an anxiety disorder Severity of anxiety ranging from 20 to 53 in Spielberger Anxiey Questionnaire Informed Consent Female gender ages 18 to 65

Exclusion criteria

Exclusion criteria: Having severe mental disorders including Schizophrenia spectrum and Bipolar; Antisocial, Borderline, Paranoid, and Schizotypal Personality Disorders Having severe personality disorders including antisocial, borderline, paranoid, and schizotypal personality disorders Evidence of cognitive impairments (orientation, attention, and impaired memory in Mini–mental state examination- MMSE) Hospitalization in a psychiatric hospital in the last month Participate in another psychological treatment at the same time

Design outcomes

Primary

MeasureTime frame
Anxiety level based of Spiel Berger's Inventory (STAI). Timepoint: Before the intervention, 2 weeks after the intervention, 2 months later in the follow-up. Method of measurement: Spiel Berger's Anxiety Questionnaire (STAI).

Secondary

MeasureTime frame
Depression score. Timepoint: Before the intervention, 2 weeks after the intervention, and 2-month follow-up. Method of measurement: Beck Depression Inventory-II (BDI-II).;Posttraumatic Cognitions. Timepoint: Before the intervention, 2 weeks after the intervention, and 2-month follow-up. Method of measurement: Posttraumatic Cognitions Inventory- 9 item (PTCI-9).;Coping Strategies. Timepoint: Before the intervention, 2 weeks after the intervention, and 2-month follow-up. Method of measurement: COPE-brief.;Emotion Dysregulation. Timepoint: Before the intervention, 2 weeks after the intervention, and 2-month follow-up. Method of measurement: ?Difficulties in Emotion Regulation Scale (DERS-16).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNarges Barzgar

University of social welfare and rehabilitation sciences

Narkises73@gmail.com+98 21 2218 0045

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026